Concepedia

Satinder Jagdev

SJ

Statistics

Publications

14

Citations

1.4K

H-Index

14

Active since

2010

Affiliations

St James's University Hospital(Current)

University of Glasgow

University of Leeds

University of Sheffield

Institute of Cancer Research

Satinder Jagdev is an author at St James's University Hospital specializing in urology, medicine, and oncology.

Top concepts

Publications per year

2010–2024

14

Publications

14

Adjuvant chemotherapy in upper tract urothelial carcinoma (the POUT trial): a phase 3, open-label, randomised controlled trial

Alison Birtle, Mark Johnson, John Chester et al. · The Lancet · 2020 · 504 citations · Full text

Phase III, Double-Blind, Randomized Trial That Compared Maintenance Lapatinib Versus Placebo After First-Line Chemotherapy in Patients With Human Epidermal Growth Factor Receptor 1/2–Positive Metastatic Bladder Cancer

Thomas Powles, Robert Huddart, Tony Elliott et al. · Journal of Clinical Oncology · 2017 · 194 citations

Skeletal complications and survival in renal cancer patients with bone metastases

Emma R. Woodward, Satinder Jagdev, Lucy McParland et al. · Bone · 2010 · 190 citations

, , +9

Phase 2 trial of dovitinib in patients with progressive FGFR3-mutated or FGFR3 wild-type advanced urothelial carcinoma

Matthew I. Milowsky, Christian Dittrich, Ignacio Durán et al. · European Journal of Cancer · 2014 · 111 citations

, , +6

Pan-AKT Inhibitor Capivasertib With Docetaxel and Prednisolone in Metastatic Castration-Resistant Prostate Cancer: A Randomized, Placebo-Controlled Phase II Trial (ProCAID)

Simon J. Crabb, Gareth Griffiths, Ellice Marwood et al. · Journal of Clinical Oncology · 2020 · 77 citations · Full text

1–5 of 14